Compare ADA Scientific Sessions vs ENDO
| 9.4 ENDO | ||
|---|---|---|
| Score | ||
| Buzzbox Score | 10.0 (Exceptional) | 9.4 (Exceptional) |
| Event Details | ||
| Dates | June 5-8, 2026 | June 13-16, 2026 (Expo: June 13-15) |
| Location | New Orleans, LA (Ernest N. Morial Convention Center) | Chicago, IL (McCormick Place West) |
| Scale | mega | large |
| Audience | ||
| Attendees | 14,000 | 8,000 |
| Exhibitors | — | — |
| Purchasing authority | ~45% | ~50% |
| Effective buyers | 6,300 | 4,000 |
| Costs | ||
| $/sqft | $41.5 | $41 |
| 10×10 space | $4,150 | $4,100 |
| All-in estimate | $8,000 – $15,000 | $8,000 – $15,000 |
| Cost per buyer | $1.83 | $2.88 |
Why exhibit at ADA Scientific Sessions
The world's largest and most prestigious diabetes research meeting, drawing 14,000+ attendees including the endocrinologists, diabetologists, and researchers who shape treatment protocols and influence formulary decisions globally. If you make glucose monitors, insulin delivery systems, CGMs, or diabetes pharmaceuticals, this is the single most important show of the year.
Why exhibit at ENDO
The premier meeting for the full breadth of endocrinology -- thyroid, diabetes, reproductive, bone, adrenal, pituitary, and obesity. 260+ exhibitors and 7,000+ attendees make this the largest endocrine-specific meeting globally. Strong KOL presence for building clinical advocacy and physician education partnerships.
Why skip ADA Scientific Sessions
Heavily research-oriented with many academic attendees who do not make purchasing decisions. If your device is not diabetes-specific (e.g., general endocrine, thyroid, or metabolic), the audience focus is too narrow. 30% international attendees may not be relevant for US-only sales teams.
Why skip ENDO
If your product is diabetes-only, ADA Scientific Sessions is the more focused and higher-attendance venue. ENDO covers the full endocrine spectrum, so your booth will compete for attention across many subspecialties. Heavy academic/research orientation means many attendees are not direct purchasers.